Skip to main content
. 2022 Aug;28(8):1559–1568. doi: 10.3201/eid2808.211787

Figure 2.

Figure 2

Summary of risk for bias assessment for a systematic review of published and unpublished studies for evidence for ribavirin treatment of Lassa fever. Bias categories: D1, bias due to confounding; D2, bias in selection of participants into the study; D3, bias in classification of interventions; D4, bias due to deviations from intended interventions; D5, bias due to missing data; D6, bias in measurement of outcomes; D7, bias in selection of the reported result. *IND 16666, unpublished study requested by P.W.H. through the US Freedom of Information Act (Birch & Davis Associates and Sherikon Inc., US Army Medical Research and Development Command, unpub. data, https://media.tghn.org/medialibrary/2019/03/Responsive_Documents_of_Peter_Horby.pdf.pdf; G.V. Ludwig, pers. comm., 2019 March 4, https://media.tghn.org/medialibrary/2019/03/Dr._Ludwig_memo.pdf). †M.-L. Orji et al., unpub. data, https://doi.org/10.20944/preprints202005.0269.v1.